المؤلفون: Amogne W; Department of Medicine, Division of Infectious Diseases, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Internal Medicine, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia., Aderaye G; Department of Internal Medicine, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia., Habtewold A; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge C1: 68, Karolinska Institute, Stockholm, Sweden; Department of Pharmacology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia., Yimer G; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge C1: 68, Karolinska Institute, Stockholm, Sweden; Department of Pharmacology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia., Makonnen E; Department of Pharmacology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia., Worku A; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia., Sonnerborg A; Department of Medicine, Division of Infectious Diseases, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge C1: 68, Karolinska Institute, Stockholm, Sweden., Lindquist L; Department of Medicine, Division of Infectious Diseases, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden.

المصدر: PloS one [PLoS One] 2015 May 12; Vol. 10 (5), pp. e0122587. Date of Electronic Publication: 2015 May 12 (Print Publication: 2015).

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: AIDS-Related Opportunistic Infections/*drug therapy , Anti-HIV Agents/*therapeutic use , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , Tuberculosis/*drug therapy, AIDS-Related Opportunistic Infections/etiology ; Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Antiretroviral Therapy, Highly Active/adverse effects ; Antitubercular Agents/administration & dosage ; Antitubercular Agents/adverse effects ; CD4 Lymphocyte Count ; Drug Administration Schedule ; Female ; HIV Infections/complications ; Humans ; Male ; Middle Aged ; Tuberculosis/etiology

المؤلفون: Yimer G; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge C1:68, Karolinska Institutet, Stockholm, Sweden; Department of Pharmacology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Gry M; Former AstraZeneca R&D, Global Safety Assessment, Molecular Toxicology, Södertälje, Sweden., Amogne W; Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; Department of Medicine, Division of Infectious Diseases, Karolinska Institute at Karolinska University Hospital Huddinge I:73, Stockholm, Sweden., Makonnen E; Department of Pharmacology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Habtewold A; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge C1:68, Karolinska Institutet, Stockholm, Sweden; Department of Pharmacology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Petros Z; Department of Pharmacology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Aderaye G; Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Schuppe-Koistinen I; AstraZeneca Innovative Medicines Personalised Healthcare & Biomarkers, Science for Life Laboratory, Solna, Sweden., Lindquist L; Department of Medicine, Division of Infectious Diseases, Karolinska Institute at Karolinska University Hospital Huddinge I:73, Stockholm, Sweden., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge C1:68, Karolinska Institutet, Stockholm, Sweden.

المصدر: PloS one [PLoS One] 2014 Apr 08; Vol. 9 (4), pp. e94271. Date of Electronic Publication: 2014 Apr 08 (Print Publication: 2014).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Retroviral Agents/*adverse effects , Antitubercular Agents/*adverse effects , Chemical and Drug Induced Liver Injury/*epidemiology, Adult ; Antiretroviral Therapy, Highly Active ; Chemical and Drug Induced Liver Injury/diagnosis ; Ethiopia ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Prognosis ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome ; Young Adult

المؤلفون: Yimer G; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Aderaye G, Amogne W, Makonnen E, Aklillu E, Lindquist L, Yamuah L, Feleke B, Aseffa A

المصدر: PloS one [PLoS One] 2008 Mar 19; Vol. 3 (3), pp. e1809. Date of Electronic Publication: 2008 Mar 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: HIV Seronegativity*, Antitubercular Agents/*adverse effects , Chemical and Drug Induced Liver Injury/*etiology , HIV Infections/*complications , Tuberculosis/*drug therapy, Adolescent ; Adult ; Aged ; Cohort Studies ; Ethiopia ; Female ; Humans ; Male ; Middle Aged ; Tuberculosis/complications

المؤلفون: Bruchfeld J; Division of Infectious Diseases, Institution of Medicine, Karolinska Institute, Huddinge University Hospital, 141 86 Stockholm, Sweden. Judith.Bruchfeld@medhs.ki.se, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S, Lindquist L

المصدر: Journal of clinical microbiology [J Clin Microbiol] 2002 May; Vol. 40 (5), pp. 1636-43.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print Cited Medium: Print ISSN: 0095-1137 (Print) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*pharmacology , Mycobacterium tuberculosis/*genetics , Mycobacterium tuberculosis/*isolation & purification , Tuberculosis, Pulmonary/*microbiology, Adolescent ; Adult ; Comorbidity ; Drug Resistance, Microbial ; Ethiopia/epidemiology ; Female ; HIV Infections/epidemiology ; Hospitals, University ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Phylogeny ; Polymorphism, Restriction Fragment Length ; Regression Analysis ; Tuberculosis, Pulmonary/epidemiology